Highly conserved cysteines are involved in the oligomerization of occludin-Redox dependency of the second extracellular loop

Antioxidants and Redox Signaling

Volumn 20, Issue 6, 2014, Pages 855-867

  Bellmann, Christian ^a   Schreivogel, Sophie ^a   Günther, Ramona ^a   Dabrowski, Sebastian ^a   Schümann, Michael ^a   Wolburg, Hartwig ^b   Blasig, Ingolf E ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE; CYSTEINE; HUMANS; OCCLUDIN; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; TIGHT JUNCTIONS;

EID: 84893847538     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5288     Document Type: Article

References (39)

1. Bal MS, Castro V, Piontek J, Rueckert C, Walter JK, Shymanets A, Kurig B, Haase H, Nurnberg B, and Blasig IE. The hinge region of the scaffolding protein of cell contacts, zonula occludens protein 1, regulates interacting with various signaling proteins. J Cell Biochem 113: 934-945, 2012.
2. Balda MS, Garrett MD, and Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 160: 423-432, 2003. (Pubitemid 36182732)
3. Blasig IE, Bellmann C, Cording J, del Vecchio G, Zwanziger D, Huber O, and Haseloff RF. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal 15: 1195-1219, 2011.
4. Blasig IE, Winkler L, Lassowski B, Mueller SL, Zuleger N, Krause E, Krause G, Gast K, Kolbe M, and Piontek J. On the self-association potential of transmembrane tight junction proteins. Cell Mol Life Sci 63: 505-514, 2006.
5. Brast S, Grabner A, Sucic S, Sitte HH, Hermann E, Pavensta ̈ dt H, Schlatter E, and Giarimboli G. The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB J 26: 976-986, 2012.
6. Brown RC and Davis TP. Calcium modulation of adherens and tight junction function. a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33: 1706-1711, 2002. (Pubitemid 34619982)
7. Brown RC and Davis TP. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun 327: 1114-1123, 2005. (Pubitemid 40142636)
8. Caraballo JC, Yshii C, Butti ML, Westphal W, Borcherding JA, Allamargot C, and Comellas AP. Hypoxia increases transepithelial electrical conductance and reduces occludin at the plasma membrane in alveolar epithelial cells via PKC-f and PP2A pathway. Am J Physiol Lung Cell Mol Physiol 300: L569-L578, 2011.
9. Cording J, Berg J, Käding N, Bellmann C, Westphal JK, Milatz S, Gü nzel D, Wolburg H, Piontek J, Huber O, and Blasig IE. Tight junctions: claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization. J Cell Sci 162: 554-564, 2012.
10. Dö rfel MJ and Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol 2012: 807356, 2012.
11. Dukes JD, Paul Whitley P, and Chalmers AD. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS One 7: e28659, 2012.
12. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, and Tsukita S. Occludin-A novel integral membrane-protein localizing at tight junctions J Cell Biol 123: 1777-1788, 1993. (Pubitemid 24012933)
13. Gaddie KJ and Kirley TL. Conserved polar residues stabilize transmembrane domains and promote oligomerization in human nucleoside triphosphate diphosphohydrolase 3. Biochemistry 48: 9437-9447, 2009.
14. Gonzalez-Mariscal L, Betanzos A, and Avila-Flores A. MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 11: 315-324, 2000. (Pubitemid 32066139)
15. Gonzalez-Mariscal L, Hernandez S, and Vega J. Inventions designed to enhance drug delivery across epithelial and endothelial cells through tha paracellular pathway. Recent Pat Drug Deliv Formul 2: 145-176, 2008.
16. Haseloff RF, Krause E, Bigl M, Mikoteit K, Stanimirovic D, and Blasig IE. Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 6: 1803-1809, 2006.
17. Klausner RD, Donaldson JG, and Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffick and organelle structure. J Cell Biol 116: 1071-1080, 1992.
18. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, and Blasig IE. Structure and function of claudins. Biochim Biophys Acta 1778: 631-645, 2008.
19. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, and Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30: 1625-1636, 2010.
20. Mark KS and Davis TP. Cerebral microvascular changes inpermeability and tight junctions induced by hypoxia/reoxygenation. Am J Physiol Heart Circ Physiol 282: H1485-H1494, 2002. (Pubitemid 34654903)
21. McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, Brooks TA, and Davis TP. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem 106: 2395-2409, 2008.
22. McCaffrey G, Willis CL, Staatz WD, Nametz N, Quigley CA, Hom S, Lochhead JJ, and Davis TP. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 110: 58-71, 2009.
23. Morgan B, Sobotta MC, and Dick TP. Measuring EGSH and H2O2 with roGFP2-based redox probes. Free Radic Biol Med 51: 1943-1951, 2011.
24. Mü ller SL, Portwich M, Schmidt A, Utepbergenov DI, Huber O, Blasig IE, and Krause G. The tight junction protein occludin and the adherens junction protein alpha-catenin share a common interaction mechanism with ZO-1. J Biol Chem 280: 3747-3756, 2005. (Pubitemid 40223843)
25. Pelis RM, Dangprapai Y, Cheng Y, Zhang X, Terpstra J, and Wright SH. Functional significance of conserved cysteines in the human organic cation transporter 2. Am J Physiol Renal Physiol 303: F313-F320, 2012.
26. Piontek J, Fritzsche S, Cording J, Richter S, Hartwig J, Walter M, Yu D, Turner JR, Gehring C, Rahn H-P, Wolburg H, and Blasig IE. Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell Mol Life Sci 68: 3903-3918, 2011.
27. Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, Piehl C, Wiesner B, Krause G, and Blasig IE. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 22: 146-158, 2008.
28. Rajasekaran SA, Barwe SP, Gopal J, Ryazantsev S, Schneeberger EE, and Rajasekaran AK. Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G124-G133, 2007. (Pubitemid 46091628)
29. Rentea RM, Liedel JL, Welak SR, Cassidy LD, Mayer AN, Pritchard KA Jr, Oldham KT, and Gourlay DM. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model. J Pediatr Surg 47: 1135-1142, 2012.
30. Roy A, Kucukural A, and Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725-738, 2010.
31. Shen L, Weber CR, Raleigh DR, Yu D, and Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73: 283-309, 2011.
32. Storjohann L, Holst B, and Schwartz TW. A second disulfide bridge from the N-terminal domain to extracellular loop 2 dampens receptor activity in GPR39. Biochemistry 47: 9198-9207, 2008.
33. Walter JK, Rueckert C, Voss M, Mueller SL, Piontek J, Gast K, and Blasig IE. The oligomerization of the coiled coil-domain of occluddin is redox-sensitive. Ann N Y Acad Sci 1165: 19-27, 2009.
34. Wang P, Wu Y, Li X, Ma X, and Zhong L. Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism. J Biol Chem 288: 3346-3358, 2013.
35. Wolburg H, Liebner S, and Lippoldt A. Freeze-fracture studies of cerebral endothelial tight junctions. Methods Mol Med 89: 51-66, 2003.
36. Yaffe Y, Shepshelovitch J, Nevo-Yassaf I, Yeheskel A, Shmerling H, Kwiatek JM, Gaus K, Pasmanik-Chor M, and Hirschberg K. The MARVEL transmembrane motif of occludin mediates oligomerization and targeting to the basolateral surface in epithelia. J Cell Sci 125: 3545-3556, 2012.
37. Yguerabide J, Schmidt JA, and Yguerabide EE. Lateral mobility in membranes as detected by fluorescence recovery after photobleaching. Biophys J 40: 69-75, 1982.
38. Yu ASL, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, and Schneeberger EE. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288: C1231-C1241, 2005. (Pubitemid 40991060)
39. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40, 2008.